Medical isotope production without highly enriched uranium

"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the m...

Full description

Saved in:
Bibliographic Details
Corporate Author: National Research Council (U.S.). Committee on Medical Isotope Production Without Highlty Enriched Uranium
Format: Electronic eBook
Language:English
Published: Washington, D.C. : National Academies Press, c2009.
Subjects:
Online Access:Freely available online
NetLibrary
MyiLibrary
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a2200000Ia 4500
001 42856
003 MY-KLNDU
005 20241219003939.0
006 m d
007 cr mnu---uuuuu
008 110210s2009 dcua ob 000 0 eng d
019 |a 435620120  |a 666970549 
020 |a 9780309130394 
020 |a 0309130395 
020 |a 9780309130400 (electronic bk.) 
020 |a 0309130409 (electronic bk.) 
020 |a 9786612239243 
020 |a 6612239247 
029 1 |a CDX  |b 10560293 
035 |a (OCoLC)367597412 
035 |a (OCoLC)ocn367597412 
039 9 |y 201102101526  |z wafi 
040 |a MMU  |c MMU  |d CDX  |d N$T  |d IDEBK 
043 |a n-us--- 
049 |a MHEA 
050 1 4 |a QD181.U7  |b N385 2009eb 
060 4 |a 2009 I-388 
060 4 |a WN 420  |b N278m 2009 
082 0 4 |a 353.008722  |2 22 
245 0 0 |a Medical isotope production without highly enriched uranium  |h [electronic resource] /  |c Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c c2009. 
300 |a 1 electronic text (xviii, 202 p.) :  |b digital, GIF, PDF, ill. 
500 |a Title from electronic title page (viewed June 1, 2009). 
504 |a Includes bibliographical references. 
505 0 |a Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility. 
516 |a Text in GIF and PDF format. 
520 |a "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply." 
530 |a Also issued in print. 
536 |a Sponsored by the National Academy of Sciences and the U.S. Department of Energy  |c DE-AM01-04PI45013 
538 |a Adobe Acrobat required for PDF version. 
538 |a Mode of access: World Wide Web. 
650 1 2 |a Molybdenum  |x supply & distribution  |z United States. 
650 2 2 |a Molybedenum  |x isolation & purification  |z United States.. 
650 2 2 |a Radioisotopes  |x supply & distribution  |z United States.. 
650 2 2 |a Technetium Compounds  |x isolation & purification  |z United States.. 
650 1 2 |a Nuclear Medicine  |x standards  |z United States.. 
650 2 2 |a Diagnostic Imaging  |z United States.. 
650 2 2 |a Radionuclide Generators  |z United States.. 
650 2 2 |a Quality Control  |z United States. 
650 0 |a Uranium  |x Isotopes. 
650 0 |a Uranium  |x Isotopes  |x Therapeutic use. 
650 0 |a Highly enriched uranium  |x Isotopes  |x Therapeutic use. 
650 0 |a Molybdenum  |x Isotopes  |x Therapeutic use. 
650 0 |a Technetium  |x Isotopes  |x Therapeutic use. 
650 0 |a Radioisotopes  |x Therapeutic use. 
650 0 |a Nuclear medicine  |x Standards  |z United States. 
655 2 |a Electronic Books. 
655 7 |a Electronic books.  |2 local 
655 4 |a Electronic books. 
710 2 |a National Research Council (U.S.).  |b Committee on Medical Isotope Production Without Highlty Enriched Uranium 
776 0 8 |i Also issued in print:  |d Washington, D.C. : National Academies Press, c2009  |w (OCoLC)310392635 
856 4 0 |z Freely available online  |u http://books.nap.edu/openbook.php?record_id=12569 
856 4 0 |3 NetLibrary  |u http://www.netlibrary.com/urlapi.asp?action=summary&v=1&bookid=285289 
856 4 0 |3 MyiLibrary  |u http://www.myilibrary.com?id=223924 
938 |a Coutts Information Services  |b COUT  |n 10560293 
994 |a 92  |b MYMHE 
999 |a vtls000043404  |c 42856  |d 42856